Short Interest in Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Increases By 45.0%

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 551 shares, a growth of 45.0% from the March 31st total of 380 shares. Based on an average daily volume of 19,756 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

Hedge Funds Weigh In On Hong Kong Pharma Digital Technology

A hedge fund recently bought a new stake in Hong Kong Pharma Digital Technology stock. StoneX Group Inc. acquired a new position in shares of Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 43,284 shares of the company’s stock, valued at approximately $36,000. StoneX Group Inc. owned about 0.39% of Hong Kong Pharma Digital Technology as of its most recent filing with the Securities & Exchange Commission.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Hong Kong Pharma Digital Technology in a research note on Friday, January 9th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

Hong Kong Pharma Digital Technology Trading Down 1.5%

Shares of Hong Kong Pharma Digital Technology stock traded down $0.01 during trading on Thursday, reaching $0.64. The company’s stock had a trading volume of 6,708 shares, compared to its average volume of 35,220. The company has a quick ratio of 2.73, a current ratio of 2.93 and a debt-to-equity ratio of 0.28. Hong Kong Pharma Digital Technology has a 12-month low of $0.37 and a 12-month high of $2.76. The business has a 50 day moving average price of $0.64 and a 200-day moving average price of $0.84.

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) last posted its quarterly earnings results on Wednesday, March 18th. The company reported $0.01 earnings per share for the quarter. The business had revenue of $3.57 million during the quarter.

About Hong Kong Pharma Digital Technology

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.